Paratus Sciences
United States, US · 3 known investors
Paratus Sciences develops first-in-class medicines for cardiometabolic and immune & inflammatory diseases by leveraging evolutionary biology and AI to identify novel drug targets. The company uses biological insights from bats and other evolved organisms to design therapeutic solutions for chronic illness.